SEI Investments
FATE icon

SEI Investments’s Fate Therapeutics FATE Stock Holding History

SEI Investments’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
138,580
+70,937
+105% +$86.4K ﹤0.01% 3007
2025
Q4 		$66.5K Sell
67,643
-78
-0.1% -$94 ﹤0.01% 3054
2025
Q3 		$85.3K Hold
67,721
– – ﹤0.01% 2736
2025
Q2 		$75.9K Sell
67,721
-122
-0.2% -$142 ﹤0.01% 2717
2025
Q1 		$53.6K Buy
+67,843
New +$83.1K ﹤0.01% 2672
2024
Q1 		– Sell
-18,066
Closed -$67.6K – 2651
2023
Q4 		$67.6K Buy
+18,066
New +$42.6K ﹤0.01% 2542
2022
Q4 		– Sell
-65,144
Closed -$1.46M – 2580
2022
Q3 		$1.46M Buy
65,144
+12,241
+23% +$354K ﹤0.01% 1669
2022
Q2 		$1.31M Buy
+52,903
New +$1.46M ﹤0.01% 1726
2021
Q4 		– Sell
-5,922
Closed -$353K – 2607
2021
Q3 		$353K Sell
5,922
-860
-13% -$67.5K ﹤0.01% 2243
2021
Q2 		$588K Sell
6,782
-12,251
-64% -$987K ﹤0.01% 2009
2021
Q1 		$1.66M Buy
19,033
+630
+3% +$60.4K ﹤0.01% 1537
2020
Q4 		$1.67M Sell
18,403
-2,242
-11% -$139K ﹤0.01% 1471
2020
Q3 		$823K Buy
20,645
+4,522
+28% +$158K ﹤0.01% 1677
2020
Q2 		$553K Sell
16,123
-8,083
-33% -$241K ﹤0.01% 1801
2020
Q1 		$538K Buy
+24,206
New +$612K ﹤0.01% 1714
2019
Q1 		– Sell
-4,360
Closed -$71K – 2926
2018
Q4 		$71K Hold
4,360
– – ﹤0.01% 2267
2018
Q3 		$71K Hold
4,360
– – ﹤0.01% 2153
2018
Q2 		$49K Buy
+4,360
New +$48K ﹤0.01% 2515

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's FATE Position: Q1 2026 in Review

SEI Investments increased its Fate Therapeutics (FATE) stake by 105% in Q1 2026, buying an estimated $86.4K and bringing the position to 138,580 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #3007.

SEI Investments first reported a position in FATE in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.67M in Q4 2020. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • SEI Investments held 138,580 shares of Fate Therapeutics worth $166K as of Q1 2026.
  • SEI Investments bought 70,937 Fate Therapeutics shares in Q1 2026, an estimated $86.4K.
  • Fate Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3007 holding.
  • SEI Investments first reported a position in Fate Therapeutics in Q2 2018 and has held it in 18 quarters since.
  • SEI Investments's Fate Therapeutics position peaked at $1.67M in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.